North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (Q34441838)
Jump to navigation
Jump to search
scientific article published on September 23, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme |
scientific article published on September 23, 2010 |
Statements
1 reference
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme (English)
1 reference
North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (English)
Evanthia Galanis
1 reference
Wenting Wu
1 reference
Caterina Giannini
1 reference
Steven McGraw
1 reference
Jann N. Sarkaria
Patrick J. Peller
Paul D. Brown
Joon H. Uhm
Kurt A. Jaeckle
23 September 2010
1 reference
81
1 reference
2
1 reference
468-475
1 reference
Identifiers
1 reference
1 reference
1 reference